SQUAWK/NEWS
Account
Account
Menu
Live News EQUITY FLASH M impact

Corbus Pharmaceuticals Completes CANYON-1 Study

Corbus completes obesity treatment study

CRBP

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.